Summary of Study ST000409
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000320. The data can be accessed directly via it's Project DOI: 10.21228/M8MP4W This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
Study ID | ST000409 |
Study Title | Metabolomic analysis of oxytocin effects on social deficits in mice (part II) |
Study Summary | The goal of this study is to determine the prosocial hormone oxytocin (OT) effects on metabolomic profiles in feces. |
Institute | University of North Carolina |
Laboratory | Sumner Lab |
Last Name | Sumner |
First Name | Susan |
Address | Eastern Regional Comprehensive Metabolomics Resource Core, UNC Nutrition Research Institute, 500 Laureate Way, Kannapolis, NC, 28081 |
susan_sumner @unc.edu | |
Phone | 704-250-5066 |
Submit Date | 2016-06-02 |
Raw Data Available | Yes |
Raw Data File Type(s) | 1r |
Analysis Type Detail | NMR |
Release Date | 2018-06-05 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR000320 |
Project DOI: | doi: 10.21228/M8MP4W |
Project Title: | Metabolomic analysis of oxytocin effects on social deficits in mice |
Project Summary: | The goal of this study was to determine the effects of the neuropeptide oxytocin (OT) on metabolomic profiles, using a mouse model of autism-like behavior, the BALB/cByJ inbred strain. We have previously reported that subchronic treatment with OT can lead to persistent reversal of social deficits in BALB/cByJ and other models of autism spectrum disorder (ASD). In this study, mice were given a subchronic regimen with either vehicle or OT, and then evaluated for social approach. At the end of the study, brain and blood were collected for metabolomic analysis. In addition, fecal samples were taken at different time points during the treatment and testing regimen. The results from this project could elucidate mechanisms underlying the prosocial effects of oxytocin, and identify new targets for the development of highly specific oxytocin-related drugs. |
Institute: | University of North Carolina at Chapel Hill |
Department: | Department of Psychiatry |
Last Name: | Moy |
First Name: | Sheryl |
Address: | CB# 7146, Chapel Hill, NC 277599 |
Email: | ssmoy@med.unc.edu |
Phone: | 919-966-3082 |
Subject:
Subject ID: | SU000430 |
Subject Type: | Mice |
Subject Species: | Mus musculus |
Taxonomy ID: | 10090 |
Species Group: | Mammal |
Factors:
Subject type: Mice; Subject species: Mus musculus (Factor headings shown in green)
mb_sample_id | local_sample_id | Treatment | Time Point | Pool |
---|---|---|---|---|
SA019987 | F_15 | OT | S1 | N |
SA019988 | F_6 | OT | S1 | N |
SA019989 | F_3 | OT | S1 | N |
SA019990 | F_1 | OT | S1 | N |
SA019991 | F_8 | OT | S1 | N |
SA019992 | F_10 | OT | S1 | N |
SA019993 | F_12 | OT | S1 | N |
SA019994 | F_5 | OT | S1 | Y |
SA019995 | F_19 | OT | S1 | Y |
SA019996 | F_2 | OT | S1 | Y |
SA019997 | F_17 | OT | S1 | Y |
SA019998 | F_14 | OT | S1 | Y |
SA019999 | F_26 | OT | S2 | N |
SA020000 | F_32 | OT | S2 | N |
SA020001 | F_25 | OT | S2 | N |
SA020002 | F_28 | OT | S2 | N |
SA020003 | F_37 | OT | S2 | N |
SA020004 | F_39 | OT | S2 | N |
SA020005 | F_22 | OT | S2 | N |
SA020006 | F_35 | OT | S2 | Y |
SA020007 | F_34 | OT | S2 | Y |
SA020008 | F_30 | OT | S2 | Y |
SA020009 | F_23 | OT | S2 | Y |
SA020010 | F_21 | OT | S2 | Y |
SA020011 | F_41 | OT | S3 | N |
SA020012 | F_55 | OT | S3 | N |
SA020013 | F_50 | OT | S3 | N |
SA020014 | F_45 | OT | S3 | N |
SA020015 | F_43 | OT | S3 | N |
SA020016 | F_46 | OT | S3 | N |
SA020017 | F_48 | OT | S3 | N |
SA020018 | F_42 | OT | S3 | Y |
SA020019 | F_52 | OT | S3 | Y |
SA020020 | F_59 | OT | S3 | Y |
SA020021 | F_57 | OT | S3 | Y |
SA020022 | F_54 | OT | S3 | Y |
SA020023 | F_61 | OT | S4 | N |
SA020024 | F_68 | OT | S4 | N |
SA020025 | F_77 | OT | S4 | N |
SA020026 | F_72 | OT | S4 | N |
SA020027 | F_70 | OT | S4 | N |
SA020028 | F_65 | OT | S4 | N |
SA020029 | F_62 | OT | S4 | N |
SA020030 | F_74 | OT | S4 | Y |
SA020031 | F_79 | OT | S4 | Y |
SA020032 | F_63 | OT | S4 | Y |
SA020033 | F_75 | OT | S4 | Y |
SA020034 | F_66 | OT | S4 | Y |
SA020035 | PF_1 | Pool | Pool | Pool |
SA020036 | PF_2 | Pool | Pool | Pool |
SA020037 | PF_3 | Pool | Pool | Pool |
SA020038 | PF_4 | Pool | Pool | Pool |
SA020039 | PF_5 | Pool | Pool | Pool |
SA020040 | F_4 | Veh | S1 | N |
SA020041 | F_7 | Veh | S1 | N |
SA020042 | F_9 | Veh | S1 | N |
SA020043 | F_11 | Veh | S1 | N |
SA020044 | F_20 | Veh | S1 | N |
SA020045 | F_16 | Veh | S1 | N |
SA020046 | F_18 | Veh | S1 | N |
SA020047 | F_13 | Veh | S1 | N |
SA020048 | F_24 | Veh | S2 | N |
SA020049 | F_40 | Veh | S2 | N |
SA020050 | F_33 | Veh | S2 | N |
SA020051 | F_38 | Veh | S2 | N |
SA020052 | F_31 | Veh | S2 | N |
SA020053 | F_29 | Veh | S2 | N |
SA020054 | F_27 | Veh | S2 | N |
SA020055 | F_36 | Veh | S2 | Y |
SA020056 | F_60 | Veh | S3 | N |
SA020057 | F_47 | Veh | S3 | N |
SA020058 | F_56 | Veh | S3 | N |
SA020059 | F_51 | Veh | S3 | N |
SA020060 | F_58 | Veh | S3 | N |
SA020061 | F_44 | Veh | S3 | N |
SA020062 | F_53 | Veh | S3 | Y |
SA020063 | F_49 | Veh | S3 | Y |
SA020064 | F_76 | Veh | S4 | N |
SA020065 | F_64 | Veh | S4 | N |
SA020066 | F_69 | Veh | S4 | N |
SA020067 | F_80 | Veh | S4 | N |
SA020068 | F_78 | Veh | S4 | Y |
SA020069 | F_67 | Veh | S4 | Y |
SA020070 | F_71 | Veh | S4 | Y |
SA020071 | F_73 | Veh | S4 | Y |
Showing results 1 to 85 of 85 |
Collection:
Collection ID: | CO000424 |
Collection Summary: | 24 hr after the social test, mice were deeply anesthetized with 5% isoflurane, followed by rapid decapitation. Brains were removed, rinsed with ice-cold water, and then rapidly dissected into the following 5 regions: forebrain, midbrain, cerebellum, hindbrain, and olfactory bulbs. The dissected parts were flash-frozen on dry ice and stored at -80o C. Samples were coded by treatment: vehicle-treated mice (n=8) and OT-treated mice (n=12). |
Sample Type: | Feces |
Treatment:
Treatment ID: | TR000444 |
Treatment Summary: | BALB/cByJ male mice (4-5 weeks in age; Jackson Laboratory, Bar Harbor, ME) were given four treatments of either vehicle or OT (1.0 mg/kg; IP) across 8 days, with at least 48 hours between each injection. Mice were evaluated in a 3-chamber choice test for social preference 24 hr after the final injection. |
Sample Preparation:
Sampleprep ID: | SP000437 |
Sampleprep Summary: | Fecal pellets were transferred into a pre-labeled MagnaLyser tube and massed. Phosphate buffer was added depending on the mass of each sample (500 uL for up to 100 mg and 1000 uL for more than 200 mg). Samples were homogenized using MagnaLyser for two 30 sec pulses and then centrifuged. The supernatant of each sample was transferred into pre-labeled 0.2 um nylon filter tube and centrifuged. A volume of each filtrate required to analyze 25 mg of sample was aliquoted, mixed with a volume of phosphate buffer to bring the total volume to 630 uL, and 70 uL of Chenomx ISTD. For a subset of samples with excess material, a total study pool was created by mixing the remaining volume. Five replicates were created, and these prepared identically to the study samples. The tubes were vortexed for 2 min on a multi-tube vortexer and centrifuged at 16,000 rcf for 4 min. A 600 µl aliquot of the supernatant was transferred into pre-labeled 5 mm (4”) NMR tubes for data acquisition on a 700 MHz spectrometer. |
Analysis:
Analysis ID: | AN000649 |
Analysis Type: | NMR |
Num Factors: | 16 |
NMR:
NMR ID: | NM000071 |
Analysis ID: | AN000649 |
Instrument Name: | Bruker Avance III |
Instrument Type: | FT-NMR |
NMR Experiment Type: | 1D 1H |
Spectrometer Frequency: | 700 MHz |